SEC kicker for Auburn football, and had to battle ulcerative colitis and Crohn's disease to make a heart-warming return.

The two main types of IBD are ulcerative colitis (UC) and Crohn's disease (CD). Do you or someone you love have moderate to ...

Icotrokinra demonstrated clinically meaningful outcomes at Week 28 in the Phase 2b ANTHEM-UC study in ulcerative colitis, with 31.7% of patients achieving clinical remission and 38.1% showing ...

The FDA has approved a new single-injection, once-monthly maintenance regimen for Eli Lilly’s Omvoh (mirikizumab-mrkz), ...

The FDA has approved a once-monthly injection of Eli Lilly’s Omvoh for maintenance therapy in adult patients with moderately ...

Ulcerative Colitis Treatment Market To Reach $12.79 Billion By 2033 Biologics, Biosimilars & Small Molecules Rise. EINPresswire/ -- According to DataM Intelligence, the ulcerative colitis treatment ...

Eli Lilly said federal regulators have approved of a single-injection, once-monthly maintenance regimen in the U.S. for its ulcerative colitis treatment Omvoh.

Market Implications: This study update could positively impact Pfizer’s stock performance by demonstrating the real-world effectiveness of tofacitinib, potentially increasing investor confidence. As ...

CESSA Phase 3 Clinical Trial Results Earn ACG Presidential Poster Distinction Among Nearly 6,000 Abstracts Next-generation Hydrocortisone Acetate (ngHCA™) Suppository Administered with Sephure® Suppos ...

The update on this study could influence Pfizer’s stock performance positively, as successful results may enhance investor confidence in etrasimod’s market potential. In the competitive landscape of ...

The new approval allows patients to transition to a single 200mg subcutaneous injection once every 4 weeks, following completion of the induction phase.

Learn about the importance of protein for ulcerative colitis, specific protein needs, and the top UC-friendly sources to support healing and minimize flares.